Christopher D. Marion
Impact in
- Hepatology top 1%
- Hepatitis C virus research
- Virology top 10%
- HIV Research and Treatment
Papers in
-
- Hepatitis C virus research 2
-
- TGF-β signaling in diseases 2
- Developmental Biology and Gene Regulation 2
- Melanoma and MAPK Pathways 2
- Pluripotent Stem Cells Research 1
- Co-authors
- Amy J. Weiner (2 shared papers)Ferruccio Bonino (2 shared papers)Cindy Christopherson (2 shared papers)Giorgio Maria Saracco (2 shared papers)J. Eric Hall (2 shared papers)Thomas Mason (1 shared paper)K. Crawford (1 shared paper)H. Mario Geysen (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (1 paper)Oncotarget (1 paper)Development (1 paper)Journal of Hepatology (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesItalyNetherlands
In The Last Decade
Christopher D. Marion
6 papers receiving 877 citations
Christopher D. Marion's Hit Papers
Peers
Comparison fields: 5 of 56
- Hepatology 646
- Virology 74
- Epidemiology 473
- Radiology, Nuclear Medicine and Imaging 164
- Rheumatology 97
Countries citing papers authored by Christopher D. Marion
This map shows the geographic impact of Christopher D. Marion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher D. Marion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher D. Marion more than expected).
Fields of papers citing papers by Christopher D. Marion
This network shows the impact of papers produced by Christopher D. Marion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher D. Marion. The network helps show where Christopher D. Marion may publish in the future.
Co-authors
The 19 scholars most cited alongside Christopher D. Marion, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Hit paper breakdown → | 1992 | 641 |
| 2 | 1997 | 144 | |
| 3 | 2017 | 74 | |
| 4 | 1991 | 51 | |
| 5 | 2018 | 9 | |
| 6 | 2000 | 7 |
About Christopher D. Marion
Christopher D. Marion is a scholar working on Hepatology, Molecular Biology, Epidemiology, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 6 papers that have together received 926 indexed citations. Recurring topics across this work include TGF-β signaling in diseases (2 papers), Hepatitis B Virus Studies (2 papers), Developmental Biology and Gene Regulation (2 papers), Melanoma and MAPK Pathways (2 papers), Hepatitis C virus research (2 papers), Liver Disease Diagnosis and Treatment (1 paper), Colorectal Cancer Treatments and Studies (1 paper) and Pluripotent Stem Cells Research (1 paper). The work is most often cited by research in Hepatology (646 citations), Virology (74 citations), Epidemiology (473 citations), Radiology, Nuclear Medicine and Imaging (164 citations) and Rheumatology (97 citations). Christopher D. Marion has collaborated with scholars based in United States, Italy and Netherlands. Frequent co-authors include Amy J. Weiner, Ferruccio Bonino, Cindy Christopherson, Giorgio Maria Saracco, J. Eric Hall, Thomas Mason, K. Crawford, H. Mario Geysen, William Cairns Smith and Tim J. Yen. Their work appears in journals such as Molecular Cancer Therapeutics, Oncotarget, Development, Journal of Hepatology and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.